Varisacumab (R 84) is an antibody. Varisacumab can be used for various biochemical studies[1]
References
[1] Johanna Breuer, et al. VLA-2 blockade in vivo by vatelizumab induces CD4+FoxP3+ regulatory T cells. Int Immunol. 2019 May 21;31(6):407-412. DOI:10.1093/intimm/dxz018
